Male Infertility Market Analysis By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay), By Treatment, And Segment Forecasts, 2014 - 2025

  • ID: 4312568
  • Report
  • 100 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Andrology Solutions
  • Aytu BioScience, Inc.
  • Bayer Group
  • Cadila Healthcare Ltd.
  • EMD Sereno, Inc.
  • Endo International plc
  • MORE
The global male infertility market is expected to reach USD 4.7 billion by 2025. Globally, increasing infertility in male and advancements in diagnostic tests have been major factors driving the market growth. In addition, growing consciousness regarding factors causing male infertility and Assisted Reproductive Technology (ART) has led to increased adoption of treatment.

Furthermore, increasing aging population, rising obesity, and other lifestyle-associated diseases causing infertility are likely to boost the market during the forecast period. In the U.S., one third of infertility cases are due to female factor, one third due to male factors, and remaining one third are unexplained.

DNA fragmentation technique was the largest segment in male infertility tests market in 2016 and is expected to maintain its dominance during the forecast period due to rapid growth in next few years. High cost and increasing adoption in developed countries due to higher sensitivity and reliable analysis of sperm DNA integrity are the key factors for its dominance.

In 2016, ART segment dominated in the treatment market due to high success rate. In Vitro Fertilization and Intracytoplasmic Sperm Injection (ICSI) are the major ARTs used. Medications include corticosteroids and hormonal therapy; however, they are effective in very few cases. Hence, low demand, less adherence, and lower cost as compared to ART are likely to slow the growth of the medication market.

Further Key Findings From the Report Suggest:
  • Rising demand of ARTs across the globe is expected to propel growth at the fastest rate from 2017 to 2025
  • DNA fragmentation technique for the testing of male infertility dominated in 2016 and is estimated to generate revenue at a rapid rate over the forecast period.
  • Oxidative stress analysis is another method gaining popularity due to accurate determination of reactive oxygen species. The test accounted second largest share in the testing market.
  • The Europe market was the largest in 2016 and is expected to maintain its dominance during forecast period due to higher awareness, strong diagnosis rate, and high adoption of costlier treatment.
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics and pharmaceutical companies in the region, and increasing healthcare expenditure.
  • Some key players include EMD Sereno, Inc.; Aytu BioScience, Inc.; Bayer Healthcare; Cadila Healthcare Ltd.; Intas Pharmaceuticals Ltd.; Halotech DNA SL; SCSA diagnostics, Inc.; and Andrology Solutions. However, EMD Sereno, Inc. currently dominates the male infertility market.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Andrology Solutions
  • Aytu BioScience, Inc.
  • Bayer Group
  • Cadila Healthcare Ltd.
  • EMD Sereno, Inc.
  • Endo International plc
  • MORE
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
2. Executive Summary
2.1. Market Snapshot
3. Male Infertility Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2014 - 2025
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. PESTEL Analysis, 2015
3.7. Male Infertility Competitive Scenario, 2016
3.7.1. Competitive landscape: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
4. Male Infertility Market: Test Outlook
4.1. Male Infertility Market Share by Test, 2016 & 2025 (USD Million)
4.2. DNA Fragmentation Technique
4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.3. Oxidative Stress Analysis
4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.4. Microscopic Examination
4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.5. Sperm Agglutination
4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.6. Computer-Assisted Semen Analysis
4.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.6.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.7. Sperm Penetration Assay
4.7.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.7.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.8. Others
4.8.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.8.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
5. Male Infertility Market: Treatment Outlook
5.1. Male Infertility Market Share by Treatment, 2016 & 2025 (USD Million)
5.2. Assisted Reproductive Technology (ART)
5.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
5.3. Medication
5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
6. Male Infertility Market: Regional Outlook
6.1. Male Infertility Market Share by Region, 2016 & 2025 (USD Million)
6.2. North America
6.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.2.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.2.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.2.4. U.S.
6.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.2.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.2.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.2.5. Canada
6.2.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.2.5.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.2.5.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.3.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.3.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.3.4. Germany
6.3.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.3.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.3.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.3.5. U.K.
6.3.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.3.5.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.3.5.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.4.4. China
6.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.4.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.4.5. Japan
6.4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.5.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.4.5.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.5. Central & South America
6.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.5.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.5.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.5.4. Brazil
6.5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.5.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.5.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.5.5. Mexico
6.5.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.5.5.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.5.5.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.6. Middle East & Africa
6.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.6.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.6.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
6.6.4. South Africa
6.6.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.6.4.2. Market estimates and forecast by test, 2014 - 2025 (USD Million)
6.6.4.3. Market estimates and forecast by treatment, 2014 - 2025 (USD Million)
7. Competitive Landscape
7.1. Competitive Environment
7.2. Strategy Framework
8. Company Profiles
8.1. EMD Sereno, Inc.
8.1.1. Company overview
8.1.2. Financial performance
8.1.3. Industries and services catered
8.1.4. Product benchmarking
8.1.5. Strategic initiatives
8.2. Endo International plc
8.2.1. Company overview
8.2.2. Financial performance
8.2.3. Industries and services catered
8.2.4. Product benchmarking
8.2.5. Strategic initiatives
8.3. Sanofi
8.3.1. Company overview
8.3.2. Financial performance
8.3.3. Industries and services catered
8.3.4. Product benchmarking
8.3.5. Strategic initiatives
8.4. Bayer Group
8.4.1. Company overview
8.4.2. Financial performance
8.4.3. Industries and services catered
8.4.4. Product benchmarking
8.4.5. Strategic initiatives
8.5. SCSA Diagnostics, Inc.
8.5.1. Company overview
8.5.2. Financial performance
8.5.3. Industries and services catered
8.5.4. Product benchmarking
8.5.5. Strategic initiatives
8.6. Andrology Solutions
8.6.1. Company overview
8.6.2. Financial performance
8.6.3. Industries and services catered
8.6.4. Product benchmarking
8.6.5. Strategic initiatives
8.7. Halotech DNA SL
8.7.1. Company overview
8.7.2. Financial performance
8.7.3. Industries and services catered
8.7.4. Product benchmarking
8.7.5. Strategic initiatives
8.8. Intas Pharmaceuticals Ltd.
8.8.1. Company overview
8.8.2. Financial performance
8.8.3. Industries and services catered
8.8.4. Product benchmarking
8.8.5. Strategic initiatives
8.9. Aytu BioScience, Inc.
8.9.1. Company overview
8.9.2. Financial performance
8.9.3. Industries and services catered
8.9.4. Product benchmarking
8.9.5. Strategic initiatives
8.10. Cadila Healthcare Ltd.
8.10.1. Company overview
8.10.2. Financial performance
8.10.3. Industries and services catered
8.10.4. Product benchmarking
8.10.5. Strategic initiatives

List of Tables

Table 1 Male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 2 Male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 3 Male infertility market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 4 DNA fragmentation technique market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 5 Oxidative stress analysis market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 6 Microscopic examination market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 7 Sperm agglutination market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 8 Computer-assisted semen analysis market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 9 Sperm penetration assay market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 10 Others market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 11 Assisted reproductive technology market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 12 Medication market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 13 Male infertility market estimates and forecast by region, 2014 - 2025, (USD Million)
Table 14 North America male infertility market estimates and forecast by country, 2014 - 2025, (USD Million)
Table 15 North America male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 16 North America male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 17 U.S. male infertility market estimates and forecast by test, (USD Million)
Table 18 U.S. male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 19 Canada male infertility market estimates and forecast by test, (USD Million)
Table 20 Canada male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 21 Europe male infertility market estimates and forecast by country, 2014 - 2025, (USD Million)
Table 22 Europe male infertility market estimates and forecast by test, 2014-2025, (USD Million)
Table 23 Europe male infertility market estimates and forecast by treatment, 2014-2025, (USD Million)
Table 24 Germany male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 25 Germany male infertility market estimates and forecast by treatment, (USD Million)
Table 26 U.K. male infertility market estimates and forecast by test, (USD Million)
Table 27 U.K. male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 28 Asia Pacific male infertility market estimates and forecast by country, 2014 - 2025, (USD Million)
Table 29 Asia Pacific male infertility market estimates and forecast by test, 2014-2025, (USD Million)
Table 30 Asia Pacific male infertility market estimates and forecast by treatment, 2014-2025, (USD Million)
Table 31 China male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 32 China male infertility market estimates and forecast by treatment, (USD Million)
Table 33 Japan male infertility market estimates and forecast by test, (USD Million)
Table 34 Japan male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)
Table 35 Central & South America male infertility market estimates and forecast by country, 2014 - 2025, (USD Million)
Table 36 Central & South America male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 37 Central & South America male infertility market estimates and forecast by treatment, 2014-2025, (USD Million)
Table 38 Brazil male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 39 Brazil male infertility market estimates and forecast by treatment, (USD Million)
Table 40 Mexico male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 41 Mexico male infertility market estimates and forecast by treatment, (USD Million)
Table 42 Middle East & Africa male infertility market estimates and forecast by country, 2014 - 2025, (USD Million)
Table 43 Middle East & Africa male infertility market estimates and forecast by test, 2014 - 2025, (USD Million)
Table 44 Middle East & Africa male infertility market estimates and forecast by treatment, 2014-2025, (USD Million)
Table 45 South Africa male infertility market estimates and forecast by test, (USD Million)
Table 46 South Africa male infertility market estimates and forecast by treatment, 2014 - 2025, (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing &forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Male infertility market summary 2016, (USD Million)
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market restraint relevance analysis (Current & future impact)
Figure 12 Penetration & growth prospect mapping
Figure 13 SWOT Analysis, By factor (political & legal, economic and technological)
Figure 14 Porter’s Five Forces analysis
Figure 15 Male infertility competitive landscape: Market position analysis (based on tests, regional presence)
Figure 16 Male infertility market, test type outlook key takeaways
Figure 17 Male infertility: Test-type movement analysis
Figure 18 DNA fragmentation technique market, 2014 - 2025 (USD Million)
Figure 19 Oxidative stress analysis market, 2014 - 2025 (USD Million)
Figure 20 Microscopic examination Market, 2014 - 2025 (USD Million)
Figure 21 Sperm agglutination market, 2014 - 2025 (USD Million)
Figure 22 Computer-assisted semen analysis market, 2014 - 2024 (USD Million)
Figure 23 Sperm penetration assay market, 2014 - 2025 (USD Million)
Figure 24 Others market, 2014 - 2025 (USD Million)
Figure 25 Male infertility market, treatment outlook key takeaways
Figure 26 Male infertility: Treatment movement analysis
Figure 27 Assisted reproductive technology market, 2014 - 2025 (USD Million)
Figure 28 Medication market, 2014 - 2025 (USD Million)
Figure 29 Regional market place: Key takeaways
Figure 30 Male infertility market: Regional movement analysis
Figure 31 North America male infertility market, 2014 - 2025 (USD Million)
Figure 32 The U.S. male infertility market, 2014 - 2025 (USD Million)
Figure 33 Canada male infertility market, 2014 - 2025 (USD Million)
Figure 34 Europe male infertility market, 2014 - 2025 (USD Million)
Figure 35 The U.K. male infertility market, 2014 - 2025 (USD Million)
Figure 36 Germany male infertility market, 2014 - 2025 (USD Million)
Figure 37 Asia Pacific male infertility market, 2014 - 2025 (USD Million)
Figure 38 China male infertility market, 2014 - 2025 (USD Million)
Figure 39 Japan male infertility market, 2014 - 2025 (USD Million)
Figure 40 Latin America male infertility market, 2014 - 2025 (USD Million)
Figure 41 Brazil male infertility market, 2014 - 2025 (USD Million)
Figure 42 Mexico male infertility market, 2014 - 2025 (USD Million)
Figure 43 MEA male infertility market, 2014 - 2025 (USD Million)
Figure 44 South Africa male infertility market, 2014 - 2025 (USD Million)
Figure 45 Competitive strategy adopted by leading players
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • EMD Sereno, Inc.
  • Endo International plc
  • Sanofi
  • Bayer Group
  • SCSA Diagnostics, Inc.
  • Andrology Solutions
  • Halotech DNA SL
  • Intas Pharmaceuticals Ltd.
  • Aytu BioScience, Inc.
  • Cadila Healthcare Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll